Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C

Hepatology

Volumn 22, Issue 4 PART 1, 1995, Pages 1050-1056

  Martinot Peignoux, Michele ^a   Marcellin, Patrick ^a   Pouteau, Michele ^a   Castelnau, Corinne ^a   Boyer, Nathalie ^a   Poliquin, Marc ^a   Degott, Claude ^a   Descombes, Isabelle ^a   Le Breton, Véronique ^a   Milotova, Veronica ^a   Pierre Benhamou, Jean ^a   Erlinger, Serge ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAN1 INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RNA ANALYSIS;

ADULT; CHRONIC DISEASE; FEMALE; GENES, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; PROGNOSIS; RNA, VIRAL;

EID: 0029084933     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90608-8     Document Type: Article

References (30)

1. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease
3. Recombinant interferon alpha therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial
4. Treatment for chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial
5. Recombinant human alpha interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France
6. Comparison of 1 or 3 MU of interferon alpha 2b and placebo in patients with chronic non-A, non-B hepatitis
7. Factors predictive of the response to interferon in patients with chronic hepatitis C
8. Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response
9. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
10. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon beta
11. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy
12. Significance of serum hepatitis C virus RNA levels in chronic hepatitis
13. Hepatitis C viremia in chronic liver disease: relationship to interferon alpha or corticosteroid treatment
14. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus
15. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection
16. Nucl Acids Res Symp Semin
17. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
18. Absence of efficacy of increased dosage schedule on the response rate during and after recombinant alpha interferon therapy
19. Traitement de l'hepatite chronique C par l'interferon lymphoblastoide comparaison d'une duree de 6 mois et d'une durée de 12 mois
20. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of the optimal conditions for specimen collection and clinical application in interferon-treated patients
21. A proposed system for the nomenclature of hepatitis C viral genotypes
22. Long-term response to high dose of interferon alpha-2b treatment of patients with chronic hepatitis C a randomized controlled multicenter trial
23. Le groupe Français pour l'étude du traitement des hépatites chroniques NANB/C
24. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon alpha 2b for 60 weeks
25. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients
26. Differential pattern of sequence heterogeneity in the hepatitis C virus E1 and E2/NS1 proteins
27. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease
28. Differential sensitivity of hepatitis C virus quasispecies to interferon alpha therapy
29. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand confirmation polymorphism analysis
30. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region